OncLive®, the leading digital provider of resources and information to
oncology professionals, will host a webinar on the practice changes for
metastatic non-small cell lung cancer (NSCLC) on June 28 at noon (EST).
The live broadcast will be hosted by H. Jack West, M.D., medical
director, thoracic oncology program, Swedish Cancer Institute, web
editor, JAMA Oncology, founder and president, Global Resource for
Advancing Cancer Education (GRACE).
“We are excited to present this webinar that will discuss benefits of
novel therapies and tackle arising issues,” said Michael J. Hennessy
Jr., president of MJH Associates, Inc., parent company of OncLive®.
“Attendees will gain insight into strategies to approach real-life
West is an internationally renowned lung cancer specialist who has
published various peer-reviewed articles and authored many book
chapters. As the president of GRACE, he plays a critical role in
providing timely and free information to patients and caregivers
affected by cancer. Currently, he is involved in research to develop a
telemedicine-based system to expand treatment options for patients with
Designed for oncologists, physicians and health care professionals
interested in learning about emerging therapies for NSCLC, the webinar
will present a brief review of new data in immuno-oncology. West will
discuss new areas of research, and attendees will learn about his
recommended first line of therapy. The webinar will also uncover
management algorithms for patients.
Attendees can submit questions before and during the webinar. For
registration and more information, visit https://www.onclive.com/live-broadcast/interpreting-recent-data-for-immunooncology-agents/.
A digital platform of resources for practicing oncologists, OncLive® offers
oncology professionals information they can use to help provide the best
patient care. OncLive.com is the official website for the MJH
Associates, Inc., Oncology Specialty Group, which publishes OncologyLive®, Oncology
Nursing News® and more. MJH Associates, Inc., is a
full-service health care communications company offering education,
research and medical media, including curetoday.com and CURE® magazine,
the largest U.S. consumer publication focused entirely on cancer.
Combining science and humanity to make cancer understandable, CURE® reaches
patients, cancer centers and advocacy groups.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180620005882/en/